Table 1.
Patient characteristics
| Characteristic | Number | Percent |
|---|---|---|
| All Patients | 66 | 100 |
| Age (years) Median (min, max) | 72 (57, 93) | |
| PSA (ng/ml)—Median (min, max) | 31.5 (1.0,64.0) | |
| Ethnicity | ||
| Non-White | 9 | 13.6 |
| White | 57 | 86.4 |
| Body Mass Index | ||
| Underweight (<18.5) | 1 | 1.5 |
| Normal (18.5–24.9) | 13 | 19.7 |
| Overweight (25.0–29.9) | 25 | 37.9 |
| Obese | 14 | 21.2 |
| Not Available | 13 | 19.7 |
| Diabetes | ||
| No | 62 | 93.9 |
| Yes | 4 | 6.1 |
| Performance Status | ||
| PS 0 | 31 | 47.0 |
| PS1-2 | 35 | 53.0 |
| Gleason score | ||
| 5–6 | 2 | 3.0 |
| 7 | 11 | 16.7 |
| 8–10 | 51 | 77.3 |
| Missing | 2 | 3.0 |
| Metastatic Volume | ||
| Low | 31 | 47.0 |
| High | 35 | 53.0 |
| Treatment Arm | ||
| ADT | 34 | 51.5 |
| ADT + Chemo | 31 | 47.0 |
| Not Available | 1 | 1.5 |
ADT Androgen Deprivation Therapy, Chemo Chemotherapy